Cornell University

Get the latest news on Cornell Technologies, CTL Events, and startups based on licensed Cornell technologies by following CTL on Twitter @Cornell_CTL.

2013 Technology News


January | February | March | April | May | June | July | August | September | October | November | December


January

$6M Gift Advances Veterinary Medical Research

January 3, 2013

The Starr Foundation, chaired by Maurice R. (Hank) Greenberg, has committed $6 million to the Cornell College of Veterinary Medicine and will create two endowed professorships in clinical research, positions that are critical for the improvement of animal health.

Gene Therapy Turns Scar Tissue into Heart Muscle

January 7, 2013

A cocktail of three specific genes can reprogram cells in the scars caused by heart attacks into functioning muscle cells.

Dr. Ash Tewari to Lead New Center for Prostate Cancer at NewYork-Presbyterian/Weill Cornell Medical Center

January 7, 2013

NewYork-Presbyterian Hospital and Weill Cornell Medical College have established the Center for Prostate Cancer, a comprehensive center dedicated to research into and the treatment of prostate cancer, which will be led by Dr. Ashutosh K. Tewari, a renowned urologist, surgeon and prostate cancer researcher.

Study Finds How Stressed-out Cells Halt Protein Synthesis

January 8, 2013

A new Cornell study unravels how cells rapidly stall protein synthesis during stress and then resume their protein-making activities once the stress has passed.

Green Inaugural Ball to Serve 3 Hunt Country Wines

January 17, 2013

Cornell grape variety 'Noiret' featured in one of the wines served at an Inaugural Ball via Hunt Country Vineyard's blend, Alchemy.

New Cornell Technology School Tightly Bound to Business

January 21, 2013

Students arrived for the first day of classes at Cornell NYC Tech, the most ambitious institution of higher education to open in New York City in decades.

Three-photon Microscopy Improves Biological Imaging

January 22, 2013

Scientists may be a step closer to cracking one of the world's most compelling mysteries: the impossible complexity of the brain and its billions of neurons.

Stealth Peptides Reports Successful Clinical Study of Oral Bendavia

January 22, 2013

Cornell startup, Stealth Peptides, reports positive oral Bendavia clinical results.

Engineers Solve a Biological Mystery and Boost Artificial Intelligence

January 30, 2013

By simulating 25,000 generations of evolution within computers, Cornell University engineering and robotics researchers have discovered why biological networks tend to be organized as modules – a finding that will lead to a deeper understanding of the evolution of complexity.

February

Cornell's Patents May Help Boost Ithaca's Economy

February 1, 2013

Producing patents isn’t a sure-fire way to boost a local economy, but it can indicate at least the potential, according to a study by the Brookings Institution that found Ithaca was 19th in the country in patents granted per capita from 2007 to ’11.

Cornell Startup's Embedded MEMS Pico-projector Turns a Smartphone Into Larger Screen Viewing Experience

February 4, 2013

Mezmeriz has commercialized an ultra-tiny pico-projector module that can be embedded into a smart phone.

Contest Harvests Names for New Wine Grapes from Cornell

February 7, 2013

After a naming challenge drew 1,100 suggestions from around the world, a Cornell breeder has revealed the secret identities of two new wine grapes: 'Arandell' and 'Aromella'.

CCTEC Director Alan Paau Interviewed About Ithaca's Patenting Rate

February 7, 2013

Ithaca boasts the 19th highest patenting rate per capita in the country. The majority of those patents are secured by Cornell University. I caught up with Dr. Alan Paau, director of CCTEC. (video)

Cornell Contributes to Ithaca Being Named Top City for Patent Issuance, Invention

February 11, 2013

In a Feb. 1 Brookings Insitution report that presents patenting trends on a regional level, Ithaca was ranked 19th nationally for most patents granted per capita, with 97 patents granted per year from 2007 to 2011.

Weill Cornell Researchers Develop Copper Depletion Therapy That Keeps High-Risk Triple-Negative Breast Cancer at Bay

February 13, 2013

An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most difficult-to-treat forms of cancer — high-risk triple-negative breast cancer.

Cornell Scientists Create New Ear Using 3D Printing and Living Cell Injections

February 20, 2013

Printing out body parts? Cornell University researchers showed it's possible by creating a replacement ear using a 3-D printer and injections of living cells.

Intel's First Factory Customer - Cornell Startup, Novomer - Touts Made-in-USA Chips

February 20, 2013

Programmable chips from Cornell startup Achronix are being fabricated onto silicon wafers by Intel.

Cornell Startup, Novomer, Completes PPC Polyol Manufacturing

February 20, 2013

Cornell startup, Novomer, has announced the world's first large-scale manufacturing run of polypropylene carbonate polyol, producing over seven tons of finished product.

Weill Cornell Researchers Solve the 3D Crystal Structure of One of the Most Important Human Proteins

February 26, 2013

Discovery of the atomic structure of a ligand-free G protein-coupled receptor (GPCR) will held design more effective drugs.

Cornell Startup's Influence Marketing Platform Acquires Influential Team

February 27, 2013

Appinions set as end-to-end influencer marketing solution with new executive hires.

March

Weill Cornell Researchers Discover How to Shutdown Cancer's Powerful Master Protein

March 4, 2013

Weill Cornell research offers patients hope for new treatments for an aggressive and common lymphoma.

Ready to Plant: 'Iron Lady', Cornell's Latest Tomato Variety, Punches Out Blights

March 14, 2013

"Iron Lady" is the first tomato to resist three major fungal diseases -- early blight, late blight and Septoria leaf spot -- plaguing New York's growers for years.

Cornell Startup, Angiocrine Bioscience, Inc., Raises $4 Million

March 15, 2013

Angiocrine Bioscience, developers of research and therapeutic products based on a portfolio of stem cell- and endothelial cell-related technologies, has raised $4 million.

New Method Developed at Cornell Makes Puffed Rice Pop with More Nutrients

March 18, 2013

A new method for making puffed rice that retains nutrients and allows producers to fortify cereals with vitamins and protein.

Cornell Startup, Alcyone Lifesciences, and DNAtrix, Inc. to Collaborate on Unique Delivery System to Treat Brain Tumors

March 20, 2013

Cornell startup, Alcyone Lifesciences, is collaborating with DNAtrix to investigate their Microcatheter System for delivery of therapeutics for brain tumors.

New Method Developed at Weill Cornell Medical College to Expand Blood Stem Cells for Bone Marrow Transplant

March 21, 2013

A research team led by Weill Cornell Medical College investigators may have solved a major issue of expanding adult hematopoietic stem cells (HSCs) outside the human body for clinical use in bone marrow transplantation — a critical step towards producing a large supply of blood stem cells needed to restore a healthy blood system.

Weill Cornell Researchers Decode Biology of Blood and Iron Disorders Mapping Out Novel Future Therapies

March 25, 2013

Control of blood and iron disorders affecting patients worldwide centers on regulating iron and blood cell production.

Wine and Dine with Cornell's Newest Grape Varieties: 'Arandell' and "Aromella'

March 25, 2013

After deciding from over 1,000 different names, Cornell University christened two new grape varieties:  'Arandell' and 'Aromella' on February 7 at Viticulture 2013, the premier grape and wine industry conference in Rochester, NY.

Weill Cornell Medical College Physicians Create Lab Grown Parts Which Promise a More Seamless Solution for Mending the Human Body

March 25, 2013

Physicians at Weill Cornell Medical College and biomedical engineers at Cornell announced that with the help of living cells, they had successfully created an exact copy of the human ear that looks and behaves like the natural one.

Cornell Virologists Have Developed First Test for a Culprit in 'Kennel Cough'

March 27, 2013

The world's first diagnostic test for a culprit in 'kennel cough' is now available at Cornell's Animal Health Diagnostic Center (AHDC).

April

CCTEC Director, Alan Paau, joins other industry experts for 2013 Dealmakers Outlook

April 1, 2013

panel of five experts from big and small pharma as well as academia were joined on February 26 by co-host Campbell Alliance, which provided an advance look at its Survey of Dealmaker Intentions, due for rollout at the BIO Annual Meeting in Chicago later this month.

Cornell Startup, Tetragenetics, Gets $826K Grant from Gates Foundation-Backed Initiative

April 3, 2013

Tetragenetics Inc. in Cambridge, Mass., an early-stage biotech that has developed a new way to produce biologic drugs, has announced an $826,000 grant and new partnerships with two major drug companies.

Amgen Inks Antigen Deal with Cornell Startup, Tetragenetics

April 3, 2013

Thousand Oaks biotech Amgen Inc. has signed a licensing deal which gives it exclusive access to an antigen being developed by Massachusetts startup Tetragenetics Inc.

Cornell Startup, Tetragenetics, to Collaborate with Pfizer in SionX Technology

April 3, 2013

Tetragenetics, a 2012 Gates Foundation phase II grant recipient and an emerging biotechnology company focused on particle-based vaccines and expression of ion channel drug targets, has entered into a collaboration agreement with an option for an exclusive license with Pfizer.

Cornell Startup, Hurel, Sees Chips as Human's Best Friend in Drug Development, Raises $9.2 Million

April 3, 2013

A biotechnology startup has developed a technology platform it claims does a better job of indicating the effect drugs would have on humans in the preclinical phase of development than animals.

PharmLogic Subsidiary and Weill Cornell Medical College to Develop and Commercialize Addiction-Fighting Vaccines

April 4, 2013

VaxLogic LLC, a wholly owned subsidiary of PharmLogic LLC, has entered into a license agreement with Cornell University to develop and commercialize new vaccines to combat addictions, including nicotine and other drugs.

Cornell Professor Researches Magnification, Compression, and Cloaking Using Light

April 7, 2013

Cornell's Alexander Gaeta, School of Applied and Engineering Physics, conducts research focusing on using light for imaging and other processing typically done today with electrons.

Cornell Startup, Pacific Biosciences, Launches the PacBio® RS II Sequencing System

April 11, 2013

Pacific Biosciences of California, Inc. announced the launch of the PacBio® RS II — a new Single Molecule, Real-Time (SMRT®) DNA Sequencing System that provides the industry's highest consensus accuracy and longest read lengths, with double the throughput from the previous version of the system.

Cornell Researchers Discover Immune Response Linked to Key Enzyme

April 11, 2013

A previously unknown function of a family of enzymes familiar to biologists may contribute to scientists’ understanding of signaling molecules involved in the body’s immune response and could help in the treatment of such diseases as rheumatoid arthritis and cancer.

Cornell Scientists Develop World's Smallest Drug Deliverer

April 12, 2013

Cornell University researchers have created a pore in “Cornell Dots”—brightly glowing nanoparticles nicknamed C-Dots—that can carry medicine. This new and improved nanoscale courier may help light up cancer cells and provide a new patient-friendly, viable option to battle cancer.

Cornell Tech Receives $133 Million to Create the Jacobs Technion-Cornell Innovation Institute (JTCII)

April 23, 2013

Cornell Tech, the applied sciences graduate school that Cornell University has planned for Roosevelt Island, has received a gift of $133 million that will help it offer an unusual two-year, two-degree master’s program.

Weill Cornell Researchers Find That Periodic Bursts of Genetic Mutations Drive Prostate Cancer

April 25, 2013

Cancer is typically thought to develop after genes gradually mutate over time, finally overwhelming the ability of a cell to control growth. But a new closer look at genomes in prostate cancer by an international team of researchers reveals that, in fact, genetic mutations occur in abrupt, periodic bursts, causing complex, large scale reshuffling of DNA driving the development of prostate cancer.

Weill Cornell Scientists Uncover Possible Lead in Developing Specific Anti-Metastatic Therapeutic Strategies

April 30, 2013

A study, reported in the April 30 issue of Cancer Discovery, offers hope that a drug based on two potentially therapeutic proteins might help keep human cancer at bay and from metastasizing.

May

Cornell Startup, Empire Robotics, Inc., Wins 2013 LES Foundation Business Plan Competition Grand Prize

May 16, 2013

Student entrepreneurs from Cornell University captured the LES Foundation 2013 International Graduate Student Business Plan Competition’s $10,000 Grand Prize for their technology spinout, Empire Robotics. 

Cornell Lab Ddevelops Fire Blight Resistant Rootstocks to Help Popular Apple Varieties Thrive

May 21, 2013

Herb Aldwinkle’s lab in upstate New York has developed fire blight resistant root stocks that popular, yet susceptible apple varieties can be grafted to while still keeping the character of the variety intact.

Cornell Startup, Hurel, Appoints Leading Pharmaceutical Executive to Board

May 21, 2013

Hurel, a provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, announced the appointment of toxicologist Dr. James S. MacDonald, PhD, DABT to the company's Board of Directors. 

Empire Genomics, LLC to Develop Diagnostic Test for Neuroendocrine Prostate Cancer with Biomarker from Cornell

May 22, 2013

Empire Genomics, a firm in the field of personalized medicine specializing in oncological molecular genomic testing, has acquired an exclusive license from Cornell for a novel DNA biomarker to develop a diagnostic test for diagnosing and determining treatment for patients with neuroendocrine prostate cancer (NEPC).

Cornell Startup, MiTeGen, to Collaborate with European Molecular Biology Laboratory (EMBL)

May 23, 2013

Structural biology tools firm MiTeGen has forged development and distribution agreements with EMBLEM, the commercial subsidiary of the European Molecular Biology Laboratory.

Cornell Startup, Optofluidics, Has More Than Doubled in Size, Expands Into New Space

May 30, 2013

Optofluidics, a nanotech startup developing a NanoTweezer system that enables the capture and analysis of proteins, viruses, and inorganic nanoparticles, has more than doubled in size since its 2011 launch and will now occupy 1,650 square feet of dedicated office and lab space at the University City Science Center in Philadelphia. 

Quantose™ from Cornell Startup, Metabolon, Inc., Used in New Prediabetes Blood Test

May 30, 2013

Health Diagnostic Laboratory, Inc. launched a new blood test for stratifying prediabetic patients based on their risk of disease progression based on the Quantose™ insulin resistance markers discovered by Metabolon.

June

Cornell Researchers and Others Closer to Fighting Malaria by Causing Kidney Failure in Mosquitos

June 2, 2013

Researchers have come a step closer to fighting malaria by isolating a chemical that causes kidney failure in mosquitoes leaving some of the mosquitoes too bloated to survive after feeding.

Smartphone-Based System from Cornell Offers New Way to Detect Disease

June 4, 2013

Cornell University engineers have created a new smartphone-based system, consisting of a plug-in optical accessory and disposable microfluidic chips, for in-the-field detection of the herpes virus that causes Kaposi's sarcoma, a type of cancer linked to AIDS.

Ultra-Sensitive Polymer from Cornell Can Detect Explosives Used in IEDs

June 5, 2013

A chemical that’s often the key ingredient in improvised explosive devices (IEDs) can be quickly and safely detected in trace amounts by a new polymer created by a team of Cornell chemists.

Weill Cornell Led Study Shows Mechanism That May Be a Cause of Most Common Childhood Cancer

June 10, 2013

Changes in an epigenetic mechanism that turns expression of genes on and off may be as important as genetic alterations in causing pediatric acute lymphoblastic leukemia (ALL).

AstraZeneca is in Talks to Test Drugs on a Microchip made by Cornell Startup Hurel

June 17, 2013

Researchers are now testing medicines on a silicon chip that could provide a better read on how a drug will work. (See end of article.)

Cornell Team Developing Solar-Powered PCR System for MDx in Resource-Poor Countries

June 20, 2013

Scientists from Cornell University and Weill Cornell Medical College are developing a solar-powered, point-of-care PCR system that has the potential to enable electricity-free molecular diagnostics in resource-poor areas of the world.

Bendavia™ from Cornell Startup, Stealth Peptides, Inc., Shown to Improve Cardiac Funtion

June 24, 2013

A presentation at the European Society of Cariology (ESC) Heart Failure Congress reports promising findings that Bendavia™ can “improve cardiac function, preserve viable myocardium and increase survival” in heart failure models.

The Humane Society of the United States Invests in Cornell Startup, Hurel Corporation

June 27, 2013

The Humane Society of the United States (HSUS) announced its investment in Hurel Corp, developers of technology that produces 3-dimensional tissue cultures that simulate and predict in vivo function of the liver and other organs for drug development and chemical testing. 

July

Urine Test from Cornell Predicts Transplanted Kidney Rejection

July 5, 2013

Weill Cornell researchers reported that a urine test can determine whether a transplanted kidney recipient is in the process of rejecting the donated organ, as well as identifying who is at risk of rejection several weeks and even months before symptoms appear.

Bendavia™ from Cornell Startup, Stealth Peptides, Inc., Shown to Treat and Prevent Kidney Damage

July 7, 2013

Studies indicate that Bendavia could be effective at both treating and preventing kidney injuries and their adverse effects.

Cornell Startup, BZL Biologics, Licenses its Antibody Against PSMA-Positive Prostate Cancers

July 15, 2013

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncologydrug development company specializing in proprietary antibody drug conjugates ('ADCs'), and BZL Biologics LLC, of New York, announced an exclusive licensing and collaboration agreement for an antibody against PSMA-positive prostate cancers.

Cornell Startup, Hurel Corporation, Introduces Hurel Human™, HurelDog™, and HurelRat™

July 16, 2013

Hurel, provider of artificial tissue constructs and microfluidic cell-based assay platforms, launched an in vitro product suite utilizing liver cells of rats, dogs and humans. It is designed for drug and toxicity testing to deliver more usefully predictive results than current methods.

Weill Cornell Presents Updated Results From Phase 3 Trial Of IVIG For Alzheimer's Disease

July 16, 2013

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer’s disease at the Alzheimer’s Association International Conference (AAIC) in Boston, Mass.

Cornell Startup, MetaStat, Inc., Named One of the Most Innovative Small Cap Cancer Stocks

July 30, 2013

MetaStat is highlighted for developing and commercializing novel diagnostic technologies and therapeutics for the early and reliable prediction and treatment of systemic metastasis. 

August

SnapDragon™ and RubyFrost™: New Apple Varieties Developed at Cornell

August 1, 2013

SnapDragon™ and RubyFrost™ have been a decade in the making, and how they’ve gone to market is a first for the Cornell apple-breeding program and the New York apple industry.

Cornell Materials Researchers Devised a Method for Nano-Length Scale Porous Polymer Films

August 2, 2013

Forming perfect porous polymer films is not enough; they need both large and small pores, and the process of making them needs to be simple, versatile and repeatable. Cornell materials researchers have devised a so-called hierarchical porous polymer film synthesis method that may help make these materials useful for applications ranging from catalysis to bioengineering.

Weill Cornell Scientists Offer New Hope for Treatment of Aggressive Cancer

August 2, 2013

Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses.

Colleges Help Ithaca Thrive in a Region of Struggles

August 4, 2013

Much of Ithaca's optimism comes from a reciprocal relationship with two institutions — Cornell University and, to a lesser degree, Ithaca College — which have poured hundreds of millions of dollars into the economy and created thousands of jobs for everyone from professors to landscapers, and also fostered new companies.

Cornell Startup, Empire Robotics, Inc., Wins 2nd Place at the Jiangsu Science and Technology Venture Competition

August 9, 2013

Empire Robotics, a Cornell University technology spinout that has developed a universal robot gripper, took home 2nd prize at the CorpStarter™ Business Accelerator competition.

Technology from Cornell Startup, BinOptics, Used in Cost-Effective Lasers for Next-Gen High-Speed Information Transfer

August 20, 2013

BinOptics Corporation, a leading manufacturer and supplier of semiconductor lasers, announced it has successfully incorporated its patented Etched Facet Technology (EFT) into a variety of silicon photonic applications to improve performance, reproducibility, reliability and quality while maintaining affordable manufacturing costs.

Weill Cornell Researchers Use Targeted Therapy to Improve Chemotherapy Effectiveness Against Aggressive Lymphoma

August 20, 2013

Researchers from Weill Cornell Medical College say their strategy has the potential to change the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) - and possibly other kinds of tumors.  

Cornell Professor Discovers How to Increase Yield and Extend Shelf Life and Freshness of Plants and Veggies

August 23, 2013

What plant scientists call senescence, consumers experience as wilted produce and overripe fruit. A team led by Cornell horticulture professor Su-Sheng Gan has identified an enzymatic fountain of youth that slows the process of leaf death, a discovery that lays the foundation for the genetics of freshness.

Cornell Startup, Metabolon, Inc., Announces Strategic Partnership with DHMRI

August 27, 2013

Metabolon, specialists in rapidly assessing metabolism in biological samples to quickly identify biomarkers and to understand metabolic effects of nutritionals, announced a partnership with the David H. Murdock Research Institute to “leverage the strengths of our organizations … to understand metabolism and ultimately answer key research questions and deliver healthy food products for consumers.” 

Cornell Scientists and Designers Create Clothes that Charge iPhones, Repel Stains, and Fight Off Allergies

August 28, 2013

Over the past seven years, fashion students in the textile nanotechnology lab have produced five prototypes inspired by nanoscience, including a dress that is able to charge an iPhone, clothes that repel stains and fight off allergies and a mask that captures toxic gases in the air.

September

Anxiety? No Problem! New Electric Vest from Cornell Can Knead Away Your Stress-Filled Day

September 3, 2013

Three Cornell students have developed a garment – embedded with piezoelectric cells and tiny motors – that gently massages the back and shoulders, mimicking a human touch.

Cornell Startup, MetaStat, Inc., Has Found the Signs to Indicate Cancer Cells Are Liable to Metastasize

September 6, 2013

MetaStat is developing a diagnostic test designed to assess metastisization risk in breast cancer patients so that with that information, the patient and her doctor can alter a post-treatment plan of action that will be more preventive than it might otherwise have been.

Cornell Startup, MetaStat, Inc., Commences Drug Development Program with New Research Facility

September 10, 2013

MetaStat, a life science company focused on understanding and treating systemic metastasis, begins a comprehensive drug development program with the opening of its new drug discovery research facility in Stony Brook, NY.

Cornell Startup, Novomer, Inc., Expanding Lab Space to Turn Waste CO2 Into Biodegradable Plastics and Other Chemicals

September 19, 2013

Novomer, which specializes in biodegradable plastics and other chemicals from renewable substances, received a $5 million Energy Department grant last month to be used in its efforts to use carbon dioxide and ethane-laden natural gas to make an array of petrochemicals used in everything from laminates and paints to disposable diapers.

Cocaine Vaccine from Weill Cornell Medical College Nears Human Trials

September 19, 2013

Dr. Ronald Crystal, chairman of Genetic Medicine at WCMC, is attaching cocaine to a modified cold virus, called an Adeno virus, to trick the body into making antibodies against cocaine and prevent it from getting to the brain.

Weill Cornell Researchers Have Teased Apart a Gene that Contributes to the Risk of Anxiety, Depression and Memory Loss

September 19, 2013

Researchers at Weill Cornell Medical College have discovered that a tiny alteration in a brain gene, found in 20 percent of the population, appears to induce shrinkage of neurons from the hippocampus (an important region for memory and emotion), reducing connectivity between brain cells.

WCMC Inventor, Sheila Nirenberg, Receives 2013 MacArthur Foundation Genius Grant

September 24, 2013

Nirenberg, associate professor in the Department of Physiology and Biophysics at Weill Cornell Medical College, was awarded a 2013 MacArthur Foundation Genius Grant for investigating fundamental questions about the nervous system and developing new kinds of prosthetic devices and robots.

Cornell Startup, Pacific Biosciences of California, Inc., Partners with Roche to Develop In Vitro Diagnostics Products

September 25, 2013

Pacific Biosciences has entered a deal with Roche to develop in vitro diagnostic products. The partnership aims to accelerate and support the transition of DNA sequencing into routine diagnostics. 

Partnership between Cornell Startup, VaxLogic, and Agenus Aimed at Vaccines for Chronic and Life-Threatening Diseases

September 29, 2013

A partnership between VaxLogic and Agenus aims at developing select addiction, allergy and respiratory vaccine candidates.

October

Cornell Startup, Hurel Corp, Enters Into R&D Collaboration with Sanofi US

October 1, 2013

Cornell Startup, Hurel Corporation, provider of advanced tissue constructs and microfluidic cell-based assay platforms, announced a multiphase R&D collaboration with Sanofi US to validate HuRELhuman™ in vitro liver tissue co-culture for use in pre-clinical drug development. 

New Apple Varieties from Cornell Have Right Attributes for Farms, Research

October 5, 2013

A partnership planted by Cornell University and New York Apple Growers LLC three years ago has blossomed into acres of  SnapDragon and RubyFrost apple trees, a pair of new and highly-anticipated additions to the state’s apple bounty.

Cornell Startup, Appinions, Inc., Releases Enhanced Algorithm

October 6, 2013

Appinions, an opinion-powered influence marketing platform, announced an update to their patented algorithm to “identify and quantify the relationship between influencers, those they influence, and those people who impact the influencers.” 

Cornell Lab Produces Wearable Technology that can Charge Devices, Repel Mosquitoes and More

October 9, 2013

When Juan Hinestroza, associate professor of fiber science and director of the Textiles Nanotechnology Laboratory, dreams about the future, he doesn't yearn for flying cars or robot butlers or cryogenically frozen brains. He just wants a clean shirt that he never has to wash.

Cornell Professor Discusses How to Engineer a Better Apple

October 9, 2013

Susan Brown, head of the apple breeding program at Cornell University, talks about the latest varieties to be released this fall.

Micro Water Sensor from Cornell Offers Growers Better Readings

October 11, 2013

Cornell researchers have developed a microfluidic water sensor within a fingertip-sized silicon chip that is a hundred times more sensitive than current devices and can be embedded in the stems of grape vines, for example.

Vaccine from Weill Cornell Medical College Blocks Cocaine from Reaching the Brain

October 11, 2013

Researchers at the Weill Cornell Medical College report that their cocaine vaccine, dAd5GNE, successfully blocked the drug from reaching the brain in primates, hence blunting the dopamine-induced high.

Cornell Deal Helps Growers Manage the Marketing, Development and Supply of New Apple Varieties

October 13, 2013

After a century of free access to new hybrids, like Empire, apple growers in New York this year have agreed to pay Cornell fees and royalties for the right to plant and sell the university's two newest varieties: SnapDragon and RubyFrost with a portion of the revenues going back into the apple research and breeding program. 

Cornell Professor Ray Wu Posthumously Awarded 2013 Ezra Technology Innovator Award

October 28, 2013

Ray J. Wu, the late Cornell professor of molecular biology and genetics who was widely recognized as one of the fathers of plant genetic engineering, from which sprang the development of widely grown rice plants resistant to pests, drought and salt, won posthumously the 2013 Ezra Technology Innovator Award.

Cornell Startup, Axium Nanofibers LLC, Raises $960K

October 30, 2013

Axium Nanofibers, developers of air and water filter products using nanofiber technologies, raised $960,000 from 22 investors of a planned $1 million financing. 

Cornell Startup, Metabolon, Inc., Signs Multi-Year Marketing Agreement for Prostarix Test

October 31, 2013

Metabolon, a leader in metabolomics-based laboratory-developed tests and research services, has signed an exclusive multi-year marketing agreement with Bostwick Laboratories, a full-service laboratory specializing in uropathology, particularly the diagnosis of urological cancers including prostate cancer. Under the agreement, Bostwick will market Prostarix, a non-invasive urine test for stratifying prostate cancer risk. 

November

AIDS Virus Protein Analysis Brings Weill Cornell Researchers Closer to HIV Vaccine

November 1, 2013

Scientists from The Scripps Research Institute (TSRI) and Weill Cornell Medical College have completed a new analysis of a key AIDS protein long considered to be one of the most difficult targets in structural biology, and their work is an important step forward in the development of an HIV vaccine.

Finger Lakes is #3 on the List of Top Wine Destinations Around the World

November 4, 2013

New York's largest producing wine region, the Finger Lakes has more than 100 wineries dotting the panoramic hills around the lakes.

Alan Paau Responds to Article About Partnering with Industry

November 12, 2013

In a Letter to the Editor, Vice Provost and CCTEC Executive Director, Alan Paau, responds to an article in the Cornell Daily Sun about Cornell's 'Startup Problem'.

Cornell Breeder in Search of the Perfect Potato

November 13, 2013

Starchy, filling, high in vitamins and minerals, potatoes serve as comfort food, fun food, a major source of nutrition, and the basis for serious cuisine. And just as chefs continue to explore and expand the repertoire of potato possibilities, plant breeders continue to breed for improved qualities.

Cornell Startup, BinOptics Corporation, Named One of North America's Fastest Growing Companies

November 18, 2013

BinOptics, a manufacturer and supplier of semiconductor lasers for optical connectivity, ranked 167 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. 

Cornell Researchers Discover Key Component to Blocking Brain Tumor Growth

November 19, 2013

Cornell study opens a path for new drugs to block brain tumor growth with fewer side effects and lower resistance rates than most conventional cancer drugs.

New Program Aims to Commercialize Cornell Technology

November 20, 2013

To provide a corporate leg up to technology opportunities and startup companies emerging from research here, the new Cornell Technology Acceleration and Maturation (C-TAM) program is designed to propel promising ideas toward commercial viability.

Cornell Startup, Optofluidics, Inc., Named a Finalist for the 2014 Prism Awards for Photonics Innovation

November 27, 2013

Optofluidics was named a finalist in the Life Science and Biophotonics category for the 2014 Prism Awards for Photonics Innovation, “a competition recognizing new products and inventions that break with conventional ideas, solve problems, and improve life through the generation and application of light-based technologies, optics and photonics.” 

Weill Cornell Scientists Find Blood Vessel Cells Can Repair, Regenerate Organs

November 27, 2013

Research from Weill Cornell Medical College shows that someday damaged or diseased organs may be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants.

December

Cornell Startup, Pacific Biosciences of California, Inc., Collaborates to Finish Genomes of 3,000 Bacterial Strains

December 3, 2013

Pacific Biosciences, provider of the PacBio RS II DNA Sequencing System, is partnering with the Wellcome Trust Sanger Institute and Public Health England to complete the sequences of 3,000 bacterial genome strains. 

Cornell Joins the National Academy of Inventors (NAI)

December 3, 2013

Cornell University has joined the National Academy of Inventors (NAI), an organization that "enhances the visibility of university and non-profit research institute technology and academic innovation."

Cornell Alum, Founder of Priceline, Named NAI Fellow

December 3, 2013

Cornell alumnus and founder of Priceline, Jay Walker has been named a Fellow with the National Academy of Inventors (NAI).

How Much Space is Left in Cornell's First MBA Class at its NYC Tech Campus?

December 4, 2013

Cornell University has admitted half of what will become its first MBA class to graduate from the school’s New York City tech campus and revealed a curriculum that requires students work part of the year in a start-up environment.

Saudi Aramco Energy Ventures LLC Joins Investment Team of Cornell Startup, Novomer, Inc.

December 10, 2013

Saudi Aramco Energy Ventures leads an investment into Cornell startup, Novomer, an emerging sustainable chemistry company developing a family of high performance, environmentally responsible polymers and chemical intermediates. The investment will fund ongoing technology platform development, construction, and enhancement of sales and marketing organization. 

Cornell Startup, Optofluidics, Inc. Launches NanoTweezer System

December 11, 2013

Optofluidics, a scientific equipment manufacturer commercializing particle analysis and manipulation technologies, announces the launch of the NanoTweezer System – a high-throughput tractor beam for nanoparticle measurement and manipulation. 

Cornell Engineers Have Developed the smartCARD System for Taking Selfies That May Save Your Life

December 12, 2013

With a new smartphone accessory, the Smartphone Cholesterol Application for Rapid Diagnostics (smartCARD), you can take an accurate reading of your cholesterol level in about a minute with your iPhone’s camera. 

Cornell Ranks 27th in NAI and IPO Top 100 Worldwide Universities Granted US Patents in 2012

December 16, 2013

The list from the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) recognizes that “innovation based on university technology has proven to be a key factor in worldwide industrial and economic development.” 

New Functionality from Cornell Startup, Achronix Semiconductor Corporation, Translates to Savings

December 17, 2013

Achronix, a manufacturer of application targeted field programmable gate arrays (FPGAs) demonstrated error-free operation of 100G Ethernet functionality using its Speedster22i® FPGA device for high bandwidth communication applications. 

Cornell Aeroponics Project Ramps Up Production of New Potato Varieties

December 17, 2013

A new aeroponics system has the potential to free up space, increase efficiency and boost production to enable new disease resistant Cornell potato varieties to enter the marketplace faster.

Latest Renderings of the New Cornell NYC Tech Campus Revealed

December 19, 2013

New artist renderings unveil a glassy, gateless campus as New York City officially hands the land on Roosevelt Island over to Cornell. 

Cornell Startup, Axium Nanofibers LLC, Raises $1.2 Million

December 24, 2013

Axium Nanofibers, developers of air and water filter products using nanofiber technologies, raised $1.2 million from 11 investors of a planned $15 million financing. 

For more archived news items, click here.